Skip to main content
. 2022 Aug 11;16:958377. doi: 10.3389/fnins.2022.958377

TABLE 3.

Effects of opioid receptor antagonists on tonic luteinizing hormone (LH) secretion in female mammals.

Antagonists Receptors Treatment routes Effects Species Ovarian states References
Naloxone μ- > κ- >> δ- i.v. Stimulatory Human Late follicular phase Quigley and Yen, 1980
i.v. Stimulatory Human Mid-luteal phase Quigley and Yen, 1980
i.v. No effect Human Early follicular phase Quigley and Yen, 1980
i.v. Stimulatory Rhesus monkey Luteal phase Van Vugt et al., 1983
i.v. No effect Rhesus monkey Follicular phase Van Vugt et al., 1983
s.c. Stimulatory Rat Ovary-intact Petraglia et al., 1984
s.c. No effect Rat OVX Petraglia et al., 1984
i.v. Stimulatory Sheep Luteal phase Malven et al., 1984
i.v. No effect Sheep Non-luteal phase Malven et al., 1984
i.v. Stimulatory Sheep Early and mid-luteal phase Brooks et al., 1986
i.v. No effect Sheep Late-luteal phase Brooks et al., 1986
i.v. No effect Human Post-menopausal Reid et al., 1983
3V Stimulatory Rat Pregnant Gallo, 1990
MBH, POA Stimulatory Sheep Luteal phase Goodman et al., 2004
WIN44,441-3 κ- i.v. Stimulatory Sheep Luteal phase Whisnant and Goodman, 1988
i.v. No effect Sheep Follicular phase Whisnant and Goodman, 1988
i.v. Stimulatory Sheep Luteal phase Yang et al., 1988
nor-BNI κ- 3V Stimulatory Rat Pregnant Gallo, 1990
3V Stimulatory Rat OVX + low E21 Mostari et al., 2013
3V No effect Rat OVX Mostari et al., 2013
MBH, POA Stimulatory Sheep Luteal phase Goodman et al., 2004
PF-4455242 κ- i.v., s.c. Stimulatory Goat OVX + low E22 Sasaki et al., 2019
Naloxonazine μ- POA Stimulatory Sheep Luteal phase Goodman et al., 2004
MBH No effect Sheep Luteal phase Goodman et al., 2004
ICI 174864 δ- 3V No effect Rat Pregnant Gallo, 1990
Naltrindole δ- MBH, POA No effect Sheep Luteal phase Goodman et al., 2004

nor-BNI, nor-binaltorphimine.

1Ovariectomized (OVX) rats treated with a diestrous level of E2.

2OVX goats treated with a luteal phase level of E2.